logo

For the Inventor, By the Inventor

Nantes, France

Valneva Se

Calculating rank
USPTO Granted Patents = 15


Forward Citations = 31

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Mario Nebenführ (8 out of 17 patents)

silverMedal Jürgen Heindl-Wruss (8 out of 18 patents)

bronzeMedal Robert Schlegl (8 out of 28 patents)

4.  Michael Weber (7 out of 24 patents)

5.  Jana Barbero Calzado (5 out of 13 patents)

6.  Andreas Meinke (5 out of 46 patents)

7.  Urban Lundberg (4 out of 21 patents)

8.  Robert Schiegl (3 out of 4 patents)

9.  Andrea Fritzer (3 out of 4 patents)

10.  Arnaud Leon (3 out of 7 patents)

11.  Klaus Heinrich Schwamborn (3 out of 9 patents)

12.  Fabien Perugi (3 out of 3 patents)

13.  Wolfgang Schüler (2 out of 12 patents)

14.  Christoph Reinisch (1 out of 6 patents)

15.  Nina Wressnigg (1 out of 3 patents)


15 patents:

1. 12605437 - SINGLE SHOT CHIKUNGUNYA VIRUS VACCINE (2026-04-21),
2. 12605436 - CHIKUNGUNYA VACCINE FORMULATIONS (2026-04-21),
3. 12214033 - Virus purification (2025-02-04),
4. 12162909 - Subunit vaccine for treatment or prevention of a respiratory tract infection (2024-12-10),
5. 12162907 - Subunit vaccine for treatment or prevention of a respiratory tract infection (2024-12-10),
6. 12053518 - Method for rescuing and producing a virus in avian cells (2024-08-06),
7. 12011477 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3 (2024-06-18),
8. 11629339 - Aseptic purification process for viruses (2023-04-18),
9. 11484587 - Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3 (2022-11-01),
10. 11406700 - Virus purification (2022-08-09),
11. 11357846 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3 (2022-06-14),
12. 11207397 - Virus purification (2021-12-28),
13. 10662412 - Aseptic purification process for viruses (2020-05-26),
14. 10660950 - Virus purification (2020-05-26),
15. 10537630 - Virus purification (2020-01-21),
Company Overview
Valneva SE is a biotechnology company based in Nantes, France, specializing in the development and commercialization of innovative vaccines. The company focuses on addressing unmet medical needs through its expertise in vaccine technology, particularly in the fields of infectious diseases. Valneva's research encompasses various therapeutic areas, leveraging advanced scientific methodologies to create effective immunization solutions. With a commitment to public health, Valneva aims to enhance global health outcomes through its pioneering vaccine products.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

15 Patents

#8 in Nantes

#1,262 in France

#40,063 in the World

Nantes, FR
Nantes, France

Valneva Se

Forward Citations = 31

20 inventors:

goldMedal Mario Nebenführ (8 out of 17 patents)

silverMedal Jürgen Heindl-Wruss (8 out of 18 patents)

bronzeMedal Robert Schlegl (8 out of 28 patents)

4.  Michael Weber (7 out of 24 patents)

5.  Jana Barbero Calzado (5 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Valneva Se. Retrieved from https://idiyas.com/company/valneva-se

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…